BlackRock, Inc. 13D and 13G filings for Viracta Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-07-08 4:56 pm Sale |
2022-06-30 | 13G | Viracta Therapeutics, Inc. VIRX |
BlackRock Inc. BLK |
542,431 1.400% |
-1,826,487 (-77.10%) |
Filing |
| 2022-02-04 4:12 pm Purchase |
2021-12-31 | 13G | Viracta Therapeutics, Inc. VIRX |
BlackRock Inc. BLK |
2,368,918 6.300% |
2,368,918 (New Position) |
Filing |